Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.
癌症成像和诊断致力于发表应用于癌症诊断和治疗的临床和研究结果。该部分旨在发表整个癌症成像领域的研究：来自放射学和核医学中临床成像常规使用的结果、来自临床试验的结果、人类和小动物的实验分子成像、CT、MRI、超声中新造影剂的研究、新技术应用和处理算法的出版物，以改进用于癌症诊断和治疗的定量成像和图像引导介入的标准化。
Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00827
Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00215
Induction of Pyroptosis and Its Implications in Cancer Management
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00971
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00082
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00179
Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00729
Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00761
Metadherin: A Therapeutic Target in Multiple Cancers
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00349
Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00078
Characterization of Pancreatic Cancer Tissue Using Multiphoton Excitation Fluorescence and Polarization-Sensitive Harmonic Generation Microscopy
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00272
Ovine Pulmonary Adenocarcinoma: A Unique Model to Improve Lung Cancer Research
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00335
Spine SBRT With Halcyon™: Plan Quality, Modulation Complexity, Delivery Accuracy, and Speed
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00319
Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00083
Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2018.00678
Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00787
Confocal-Assisted Multispectral Fluorescent Microscopy for Brain Tumor Surgery
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00583
Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00791
MicroRNA and mRNA Interaction Network Regulates the Malignant Transformation of Human Bronchial Epithelial Cells Induced by Cigarette Smoke
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01029
Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2018.00679
Specificity of Biogenic Selenium Nanoparticles for Prostate Cancer Therapy With Reduced Risk of Toxicity: An in vitro and in vivo Study
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01541
Precision Medicine in Lymphoma by Innovative Instrumental Platforms
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01417
Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00924
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01547
The Interplay Between the DNA Damage Response, RNA Processing and Extracellular Vesicles
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01538
“Après Mois, Le Déluge”: Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00983
MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2)
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00495
Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01416
Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00160
Role of Regenerating Islet-Derived Protein 3A in Gastrointestinal Cancer
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01449
Mutation Spectrum of Cancer-Associated Genes in Patients With Early Onset of Colorectal Cancer
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00673
The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00186
Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01425
Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01356
Role of Sirtuins in Tumor Angiogenesis
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01516
Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2018.00657
Spray Fluorescent Probes for Fluorescence-Guided Neurosurgery
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00727
Prediction of Metabolic Syndrome for the Survival of Patients With Digestive Tract Cancer: A Meta-Analysis
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00281
Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00872
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01056
Identification of RE1-Silencing Transcription Factor as a Promoter of Metastasis in Pancreatic Cancer
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00291
BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00225
SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01035
Reliability and Agreement of the 10-Repetition Maximum Test in Breast Cancer Survivors
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00918
Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00028
Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00055
Integrative Analysis Reveals Across-Cancer Expression Patterns and Clinical Relevance of Ribonucleotide Reductase in Human Cancers
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00956
Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01451
Taiwanin E Induces Cell Cycle Arrest and Apoptosis in Arecoline/4-NQO-Induced Oral Cancer Cells Through Modulation of the ERK Signaling Pathway
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01309
Pigment Epithelium-Derived Factor Promotes the Growth and Migration of Human Esophageal Squamous Cell Carcinoma
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.01520
On the Feasibility of Stereotactic Radiosurgery With 5.0 and 10.0 mm MLC Leaves as a Function of Target Size and Shape
来源期刊：Frontiers in OncologyDOI：10.3389/fonc.2019.00741
